As the global economy mends, the 2021 growth of Warts Therapeutics will have significant change from previous year. According to our (LP Information) latest study, the global Warts Therapeutics market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Warts Therapeutics market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Warts Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Warts Therapeutics market, reaching US$ million by the year 2028. As for the Europe Warts Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Warts Therapeutics players cover GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd, Phio Pharmaceuticals Corporation, and Pfizer, Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Warts Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Common Warts
Plantar Warts
Flat Warts
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Homecare
Specialty Clinics
Dermatologist
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
GlaxoSmithKline plc
Teva Pharmaceutical Industries Ltd
Phio Pharmaceuticals Corporation
Pfizer, Inc
Verrica Pharmaceuticals
Bausch Health Companies, Inc
Prestige Consumer Healthcare Inc
Taro Pharmaceutical Industries Ltd
Cipla Ltd
Novan Inc
AIM ImmunoTech, Inc